117.19
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $117.19, with a volume of 326.40K.
It is up +0.85% in the last 24 hours and down -1.64% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$116.20
Open:
$116.17
24h Volume:
326.40K
Relative Volume:
0.59
Market Cap:
$5.18B
Revenue:
$3.03B
Net Income/Loss:
$237.44M
P/E Ratio:
23.30
EPS:
5.03
Net Cash Flow:
$450.04M
1W Performance:
+5.52%
1M Performance:
-1.64%
6M Performance:
-35.25%
1Y Performance:
-47.33%
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TFX
Teleflex Incorporated
|
117.19 | 5.13B | 3.03B | 237.44M | 450.04M | 5.03 |
![]()
ISRG
Intuitive Surgical Inc
|
495.86 | 175.16B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
185.32 | 52.63B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
91.86 | 45.46B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
275.16 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
263.51 | 20.05B | 2.90B | 467.20M | 306.90M | 6.37 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Jun-21-23 | Downgrade | Needham | Buy → Hold |
May-30-23 | Initiated | CL King | Buy |
May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Oct-26-22 | Initiated | Mizuho | Neutral |
Oct-14-22 | Resumed | Stephens | Overweight |
Oct-12-22 | Initiated | Jefferies | Hold |
Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jul-06-22 | Initiated | Wolfe Research | Outperform |
May-09-22 | Initiated | BofA Securities | Neutral |
Apr-13-22 | Initiated | Truist | Hold |
Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Sep-07-21 | Resumed | Raymond James | Outperform |
Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Jan-06-21 | Reiterated | Needham | Buy |
Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Jan-31-20 | Reiterated | Needham | Buy |
Aug-02-19 | Reiterated | Needham | Buy |
Jun-11-19 | Initiated | Wells Fargo | Outperform |
Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
Feb-22-19 | Reiterated | Needham | Strong Buy |
Oct-16-18 | Initiated | Barclays | Equal Weight |
Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
Aug-03-18 | Reiterated | Needham | Buy |
May-14-18 | Reiterated | Needham | Buy |
May-04-18 | Reiterated | Needham | Buy |
Apr-04-18 | Initiated | Goldman | Neutral |
Nov-10-17 | Resumed | Piper Jaffray | Overweight |
Nov-03-17 | Reiterated | Needham | Buy |
Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Sep-06-17 | Reiterated | Needham | Buy |
Mar-07-17 | Initiated | Needham | Buy |
Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
What are analysts’ price targets for Teleflex Incorporated in the next 12 monthsRealize exceptional returns through smart trading - jammulinksnews.com
How volatile is Teleflex Incorporated stock compared to the marketHigh-impact investment strategies - jammulinksnews.com
Is Teleflex Incorporated a growth stock or a value stockMaximize your returns with expert insights - jammulinksnews.com
When is Teleflex Incorporated stock expected to show significant growthAchieve superior returns through strategic trading - jammulinksnews.com
What You Can Learn From Teleflex Incorporated's (NYSE:TFX) P/E - 富途牛牛
What drives Teleflex Incorporated stock priceExplosive trading opportunities - PrintWeekIndia
Is Teleflex Incorporated a good long term investmentHigh-performance investment picks - PrintWeekIndia
Can Teleflex Incorporated stock recover from recent declineRapid portfolio appreciation - jammulinksnews.com
What analysts say about Teleflex Incorporated stockExponentially increasing returns - PrintWeekIndia
Teleflex to Announce Q2 2025 Results: Join the Live Call July 31 - MSN
Analysts Estimate Teleflex (TFX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Teleflex Incorporated Stock Analysis and ForecastTremendous portfolio expansion - Autocar Professional
Teleflex stock hits 52-week low at 110.83 USD By Investing.com - Investing.com India
Teleflex stock hits 52-week low at 110.83 USD - Investing.com
Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation - Yahoo Finance
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information - GlobeNewswire
Teleflex Sets Q2 2025 Earnings Call Date: Key Financial Updates Coming July 31 - Stock Titan
Morgan Stanley Remains a Buy on Teleflex (TFX) - The Globe and Mail
Teleflex Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Benzinga
Teleflex stock price target lowered to $130 by RBC Capital - Investing.com Nigeria
Teleflex stock hits 52-week low at $115.77 By Investing.com - Investing.com India
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):